Identification of Gut Microbiota Biomarker Genera Distinguishing Wild and Captive Animals (A) Top 50 discriminative genera selected by random forest classifier, ranked by mean decrease accuracy. by Lin Xu (94491)

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. by Joseph Rabin (7399436)

Subjects:

Correlation between hub genes and 50 hallmark signaling pathways. by Jiyong Zhang (2498740)

Multiple trauma and hemorrhagic shock induce a transcriptional immune response. by Marc-Alexander Oestreich (13961375)

Chamber. by Yoichiro Kitajima (4319455)

Subjects:

Microstructure Evolution of the Mg-5.8 Zn-0.5 Zr-1.0 Yb Alloy During Homogenization by Lu Li (14069)

“…After homogenization, most of the eutectic phases dissolve into the matrix, except for a small amount of Mg-Zn-Yb phase. The area fractions of residual secondary phase decrease from 5.54% in the as-cast alloy to 0.59% in the well-homogenized sample. …”

Sensitivity analysis for IC₅₀ and <i>ε</i>_max as a function of measurement time. by Hope Murphy (8843516)

Neo-cy5 uptake is not decreased in Δ<i>vchM</i>. by André Carvalho (3495140)

No discernible effect of high-dose 5-HT_2AR blockade on error rates in the reward-size task. by Yukiko Hori (299784)

The IC50 value of Tan in normal esophageal HET-1A cells. by Dong Yang (141041)

Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

Post-losartan treatment prevented SARS-CoV-2 spike protein-induced decreased cognitive impairment but not pre-losartan treatment. by Mackenzi Meier (19251139)

HoxA9-ER directly represses <i>Cebpa</i> gene expression in myeloid cells. by Lei Peng (260321)

Deletion <i>of bipA</i> in <i>E. coli</i> and <i>S.</i> Typhimurium results in a growth defect at low temperatures. by Eunsil Choi (8271039)

Clinical evolution at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

SaFi, laboratory, radiology, vaccine status, and inpatient treatment data. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Relationship between a simplified SCOPE score at start of treatment with anakinra and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of medical discharge at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Clinical outcome at 60 days based on SaFi, anakinra and a simplified SCOPE. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Comorbidities and severity scales at admission for the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects: